Does homocysteine-lowering therapy prevent cardiovascular events in adults with cardiovascular disease?
Metadata[+] Show full item record
Lowering plasma homocysteine levels with folic acid and B vitamin supplementation does not reduce the risk of myocardial infarction (MI) or cardiovascular (CV) mortality more than placebo. (SOR A, based on consistent randomized controlled trials [RCTs] and meta-analyses.)
Evidence-based practice 11, no. 08 (2008): 06-07